Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03393143 · ClinicalTrials.gov registry record
A Naturalistic Experiment Evaluating the Impact of Medicaid Treatment Reimbursement Changes on Opioid Prescribing and Patient Outcomes Among Patients With Back Pain
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 2,748
- Enrollment target
NCT03393143: Completed study, sponsored by Kaiser Permanente.
NCT03393143 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 2,748 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03393143 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 2,748 participants
- Enrollment target
Study Summary
Back on Track is a quasi-experimental, mixed-methods study of a unique natural experiment that will answer the question: what is the comparative effectiveness of different payer or health-system strategies that aim to prevent unsafe opioid prescribing? The State of Oregon is enacting a Medicaid reimbursement policy to enhance access to evidence-based non-pharmacotherapeutic treatment options while restricting reimbursement for opioids for back pain. We will assess whether the policy decreases unsafe opioid prescribing and improves patient outcomes compared with usual back pain treatment practices in a comparable state, California, that is not changing Medicaid payment policy.
Primary Outcome
Modified 10-item version of the Brief Pain Inventory-Short Form (BPI-SF), composite of pain intensity (3 items) and pain-related interference (7 items) subscales (10 items total; continuous)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,748 participants |
| Start Date | 2018-05-31 |
| Est. Completion | 2020-09-30 |
What the finished NCT03393143 record still lists
NCT03393143 is an observational study that tracks outcomes without assigning an intervention. Its 2,748 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03393143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03393143 about?
NCT03393143 is a clinical study titled "A Naturalistic Experiment Evaluating the Impact of Medicaid Treatment Reimbursement Changes on Opioid Prescribing and Patient Outcomes Among Patients With Back Pain". Back on Track is a quasi-experimental, mixed-methods study of a unique natural experiment that will answer the question: what is the comparative effectiveness of different payer or health-system strategies that aim to prevent unsafe opioid prescribing? The State of Oregon is enacting a Medicaid reim...
What is the current status of trial NCT03393143?
This trial is currently completed. The enrollment target is 2,748 participants. The study started on 2018-05-31. Estimated completion is 2020-09-30.
Who is sponsoring clinical trial NCT03393143?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06085833 · 2,706 participants · NA
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI